ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
VistaGen Therapeutics Inc

VistaGen Therapeutics Inc (VTGN)

5.28
0.71
(15.54%)
At close: March 28 04:00PM
5.28
0.71
( 15.54% )
After Hours: 04:30PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.28
Bid
5.11
Ask
5.28
Volume
1,232,805
4.57 Day's Range 5.67
1.62 52 Week Range 24.71
Market Cap
Previous Close
4.57
Open
4.59
Last Trade
95
@
5.12
Last Trade Time
16:29:16
Financial Volume
$ 6,359,348
VWAP
5.1584
Average Volume (3m)
268,308
Shares Outstanding
27,025,209
Dividend Yield
-
PE Ratio
-2.40
Earnings Per Share (EPS)
-2.19
Revenue
-227k
Net Profit
-59.25M

About VistaGen Therapeutics Inc

Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five ... Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
1970
VistaGen Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VTGN. The last closing price for VistaGen Therapeutics was $4.57. Over the last year, VistaGen Therapeutics shares have traded in a share price range of $ 1.62 to $ 24.71.

VistaGen Therapeutics currently has 27,025,209 shares outstanding. The market capitalization of VistaGen Therapeutics is $142.15 million. VistaGen Therapeutics has a price to earnings ratio (PE ratio) of -2.40.

VTGN Latest News

Vistagen to Present at Stifel 2024 Virtual CNS Days

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Vistagen to Present at TD Cowen 44th Annual Health Care Conference

Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G* (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §...

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G/A   Under the Securities Exchange Act of 1934 (Amendment No. 1...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.0825.71428571434.25.674.11622010714.36133239CS
40.030.5714285714295.255.673.91142490424.36009664CS
120.418.418891170434.875.863.91142683084.88094943CS
260.11.93050193055.185.862.45014719294.14587403CS
520.85519.32203389834.42524.711.6215066735.68739732CS
156-59.22-91.813953488464.5106.51.62339563817.06128721CS
260-30.72-85.333333333336106.51.62254300521.94603257CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.17
(69.59%)
1.62M
SBFMSunshine Biopharma Inc
$ 0.0834
(39.46%)
9.16M
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
100
SMTCSemtech Corp
$ 30.61
(11.31%)
544.95k
DAREDare Bioscience Inc
$ 0.55
(11.09%)
2.96k
XTKGX3 Holdings Company Ltd
$ 0.6802
(-31.30%)
664.23k
PLSEPulse Biosciences Inc
$ 7.09
(-18.27%)
2.48k
BDRXBiodexa Pharmaceuticals PLC
$ 1.4301
(-11.73%)
258.65k
VVOSVivos Therapeutics Inc
$ 4.22
(-11.72%)
10.2k
RNACCartesian Therapeutics Inc
$ 0.58
(-11.69%)
18.26k
SBFMSunshine Biopharma Inc
$ 0.0834
(39.46%)
9.16M
CRKNCrown Electrokinetics Corporation
$ 0.065
(8.51%)
3.33M
AAPLApple Inc
$ 171.30
(-0.13%)
3.14M
MSFTMicrosoft Corporation
$ 420.09
(0.01%)
2.5M
INTCIntel Corporation
$ 44.13
(-0.05%)
2.32M

VTGN Discussion

View Posts
fink fink 1 month ago
Not at all.
Pharma is just a time suck
That other dipped below .40

Had to dig up funds where I can. This will run above $6 now LOL
πŸ‘οΈ0
Picks77 Picks77 1 month ago
Bad news?
πŸ‘οΈ0
fink fink 1 month ago
Rolling all my gains into TELL.
Keeping 250 share for "what if ?"
Good luck to all.
πŸ‘οΈ0
fink fink 2 months ago
Todays news is not what I was looking for, but will take the excitement.
πŸ‘οΈ0
fink fink 2 months ago
https://ih.advfn.com/stock-market/NASDAQ/vistagen-therapeutics-VTGN/stock-news/92941149/form-8-k-current-report
πŸ‘οΈ0
fink fink 3 months ago
$5+ by EOY?
πŸ‘οΈ0
fink fink 4 months ago
Nice calm rise from the bottom.
I hope!
πŸ‘οΈ0
James salmon James salmon 5 months ago
I would think so, lots of cash, no need to raise any money anytime soon and low share count.
πŸ‘οΈ0
fink fink 5 months ago
Bottom in?

I'd love to see it test the low a few more times.
πŸ‘οΈ0
fink fink 5 months ago
They have an impressive pipeline.
But it's a pharma play. A time suck

They are in phase 3 for their first drug. Once they get those results they will submit to the FDA for approval. Be a share holder before that.

I think if you see volume off the chart, buy.
Insiders and family are loading

The 3 drugs alone could be a 5+ year stretch befor all are approved.

And who knows if the entire Company is bought out for $Billions?

No one can put a date on anything. Even when the FDA gives their PUDFA date, it's not a given. God only knows what the FDA review will pop up with.
Your not going to see $50+ till approval or a buy out.

If all three become block buster treatments, this might be $200+

I wish I had a spare $10k to risk in here.
👍️ 1 🤚 1
The_Q The_Q 5 months ago
A buddy told me this stock is $50-70 summer 2024, why?
πŸ‘οΈ0
bikaver bikaver 6 months ago
VTGN.....from 16.16 to the 4.20's......very profitable short.....GLTA
πŸ‘οΈ0
fink fink 6 months ago
Now here we go
That took some more time than I thought, but it can go even better.
I might get my starter after all.,
πŸ‘οΈ0
fink fink 6 months ago
This price is the hair in the biscuit. Hanging in there like a champ. I expected this below $4 by now.
Is this the new bottom after all that volume?
πŸ‘οΈ0
fink fink 7 months ago
I think this one is in Phase3

But they have to submit the package first.
That's where we are. I don't know what is left in their phase 3 trials.

Can you imagine the pure hell it must be to compile all that crap in a format the FDA wants?
It makes my head hurt thinking about it. There are Companies that do that. I'd love to know if these egg heads are doing that in-house or have outsourced to a third party?
That would be a good question for the Company. It would give a little more confidence.

The FDA will allow that kind of PR. Even all that shit is regulated and can give a new drug review a bump in the road. They have to be very careful what they put out.

But it's definitely getting exciting.
πŸ‘οΈ0
fink fink 7 months ago
For the first drug yes. They posted positive phase 3 results. The anxiety or depression spray?
The stock will get a sweet run on the PR that they have submitted the entire package to the FDA for review.
That is close. It could come any week.,
It's why the stock has not pulled back more. All shareholders are holding. The float is being held tight.
And with Fuji coming in funding the Menopause thingy? Wow! That gives great confidence thst they will never need toxic funding from dilution.

You'd expect if it did tank, they would buy back shares too

I really wanted to see this crush below $4
I don't think that is possible now.

I wish I had a spare $12k to put in this.
I'm lucky to muster $1,200
I got too much mo ey tied up dead in other shells. Thanks Brandon for killing American confidence in going public. Killed my gravy train
πŸ‘οΈ0
castmaster castmaster 7 months ago
So we are in the beginning of the end of the process I guess ?
πŸ‘οΈ0
fink fink 7 months ago
It can be 5+ years from the start of the process from phase 1 to the end of phase 3 where they submitt their info. Once the FDA gets it....90 says or so. Every drug is different. Some get fast tracked. The FDA has a page where they publish the PDUFA date. That's their gestimation on their review findings. Once it gets close to that date and it hasn't been kicked back. It gets exciting. The FDA can be picky. I've seen drugs kicked back on wording. Stupid shit. Like they didn't use blue ink? Minor stuff like that happens fast in the review. We get over the first 45 days! Hello!

I'm not sure how the FDA is today after all the heat they are getting over the COVID vaxxx scam.
Rubber stamp what the shadow government wants destroyed their street cred fast.

It's one reason a New Drug patent should get a good 35years of Global protection. The shit they have to go through
πŸ‘οΈ0
castmaster castmaster 7 months ago
Is it Usually a long wait for a 501?
πŸ‘οΈ0
purdue purdue 7 months ago
Didn't VGTN get FDA fast track designation for one of its drugs in the pipeline several months ago?
πŸ‘οΈ0
fink fink 7 months ago
I forget what they call it but a FDA 501 new drug approval to market and sell.

That's the king shit. Then MMs will kill the run and short the hell out of it. That will continue till a marketing or buy out PR happens.

We already have Fuji throwing money at them on todays product in phase 2

Wait till the FDA stamps it.
300-800% run is my prediction. It's not just one drug but a pipeline. They won't sell out. They are going to milk these 3 drugs with positive Q reports for the next 25+ years.
It would take one hell of a buy out to get these guys to give it up.

Positive news like this will keep the stock from falling. This could very well be the new bottom.

I'd buy this for my wife today. She keeps both A/Cs at 65degrees. All the dogs and me are on the front porch having coffee in the BAMA heat.
And getting out of the shower is fridgid hell
πŸ‘οΈ0
castmaster castmaster 7 months ago
What would you say the big news in the pipe line is ?
πŸ‘οΈ0
fink fink 7 months ago
Looking good for the second drug in the pipeline.
I guess no one died in phase 2. People tolerated it and they see positive outcomes.

News means they are having positive results or there would be no news.

As good as this news is, it's not the big one that will move the Market cap. Not yet. It's still in accumulation mode.
πŸ‘οΈ0
castmaster castmaster 7 months ago
Nice news out
πŸ‘οΈ0
fink fink 7 months ago
Looking strong.
Anyone ready to say the bottom is in?
I was hoping for sub $4.75

Time to move my BIDs up. Had my bait set too deep. Oh well
πŸ‘οΈ0
fink fink 7 months ago
Vista Gen knows it's git a powerful pipeline.
This is what I look for as an excellent sign, this is going to be big.
Sales and marketing deals is cherry. Buts outs aren't bad, but why sell out when you know your sitting on 3 mega $B drugs.

https://ih.advfn.com/stock-market/NASDAQ/vistagen-therapeutics-VTGN/stock-news/91966030/vistagen-and-fuji-enter-exclusive-negotiation-agre
πŸ‘οΈ0
fink fink 7 months ago
Not sure, this has powerful potential. Like viagra type potential. But where Viagra is more psychological and you know if it works. Psychosomatic treatment are more determined by people's mental needs and state of mind. If you believe it helps, then it helps. You score a customer for life. A lot like wearing clothes that make you feel good. Its all mental. It's funny, my dad was a doctor fresh out of Tulane m/ Charity hospital. He saw his fair share of the crazies in the 50s. He was then sent to be a doctor for an entire county up North. He did everything, and saw everything. He was the only pharmacy too. The county loved him. He had these 3 different colored sugar pills he sold for anxiety and stress. Everyone started out with the yellow. If things got tense he'd upped the strength to the Blue. The green was left for real world stress. If it wasn't for those sugar piles he would have starved while working 150 hours a week aging in dog years. So we have that aspect going for us.

Take a look at TR&RI. Alzheimer's drug that can focus treatment meds to one particular spot instead of going all over the body. South Korea Bio, Low under 450K float. Explosively low float. .25-.45 cent stock. BID sitting is dead money. I think there are a few of us that like to paint it up for kicks and giggles. Spread is close to 100% most weeks. I've set a few ghost Bids and paint. It gets knocked back down where you really score your lotto tickets.I got my $5k in it, so I'm good. Waiting on news.
πŸ‘οΈ0
BurgerKing82 BurgerKing82 7 months ago
Any other good Bios with similar potential?
πŸ‘οΈ0
Triple nickle Triple nickle 7 months ago
Added a few
πŸ‘οΈ0
fink fink 7 months ago
Set your limit BID buys and pray you get a load before they PR they have all paperwork submitted to the FDA.

Have your limit sells set for that. Don't get greedy.

After that run and pull back, get set up for the FDA approval PR. The FDA will publish a PDUFA date to give some sense of how much time we have to load.

Same thing will happen on FDA approval. A great run to be killed by shorts. Cash in.

It has to show it's going to sell or get a buy out.
That's when it turns into a long term hold.
πŸ‘οΈ0
AISI304 AISI304 7 months ago
Agreed. Early Aug. was sweet, late Aug. bitter.
Gotta go after the low-hanging fruit, then book.
πŸ‘οΈ0
nate2028 nate2028 7 months ago
Yea I exited here a long time ago. You had to be so fast to catch the little rally
πŸ‘οΈ0
AISI304 AISI304 7 months ago
Hmm every little rally stopped after the p&d.
Guess we’ll see what its flippers do this fall.
πŸ‘οΈ0
fink fink 7 months ago
It's how these do after good news.
My first low alert is $3.99
I'll follow it down too.
Anyone know the PDUFA dates for the first spray? Best be in thick before.

I expect not to hear anything more till the FDA 501.
I got my Pharma perps looking at it too.
πŸ‘οΈ0
bikaver bikaver 7 months ago
VTGN.....Falling back to 3?
πŸ‘οΈ0
fink fink 7 months ago
https://www.businesswire.com/news/home/20230810272661/en/
πŸ‘οΈ0
fink fink 7 months ago
Pharma plays are always the target of MM short attack after good news. Even an FDA 501 approval.
You have to be fast on your feet till the drug is sold, bought out or shows it's going to be a block buster $ maker.
Even after a 501 it still needs to show it has market potential.

I'd imagine this will get bought out by a Big Pharma before its gets too high. Depression is a $ maker.
πŸ‘οΈ0
retireat40 retireat40 7 months ago
No chance. HKD float was something like 300k. This is 11 million.
πŸ‘οΈ0
Prominent Capital Prominent Capital 8 months ago
I have a feeling that this will go like $HKD. IMO
πŸ‘οΈ0
retireat40 retireat40 8 months ago
Yep. Turned into a flaming POS.
πŸ‘οΈ0
nate2028 nate2028 8 months ago
Yikes this thing isn’t going anywhere
πŸ‘οΈ0
retireat40 retireat40 8 months ago
Hope it starts soon. Bleeding slowly into the 6’s today.
πŸ‘οΈ0
retireat40 retireat40 8 months ago
As of August 10, 2023, the Company had 9,362,444 shares of common stock outstanding.
πŸ‘οΈ0
retireat40 retireat40 8 months ago
β€œSince June 30, 2023 and through August 10, 2023, the Company sold and settled an aggregate of 1,487,293 shares of common stock under its Sales Agreement with Jefferies and received gross cash proceeds of $16,893,700. Additional sales of 1,965,940 shares under the Sales Agreement are expected to settle on or before August 14, 2023, subject to customary settlement procedures, for expected gross cash proceeds of $15,172,023.”
πŸ‘οΈ0
TB TB 8 months ago
6.97 Quote: soon again about $2 - well over $40 - just sick whoever bought it
πŸ‘οΈ0
Welsh_Dragon Welsh_Dragon 8 months ago
Proof?
πŸ‘οΈ0
shankapotamus shankapotamus 8 months ago
The pump hasn’t even started. Hold.
πŸ‘οΈ0
retireat40 retireat40 8 months ago
They’ve increased the float by about 4 million in the last couple of weeks. Closer to 10 million now.
πŸ‘οΈ0
retireat40 retireat40 8 months ago
Looks like this will hang in this region or slowly bleed back to 5’s unless more stellar news is released.
πŸ‘οΈ0
nate2028 nate2028 8 months ago
Wow they are really keeping the price suppressed
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock